Lead Product(s) : Naftopidil
Therapeutic Area : Nephrology
Study Phase : Phase IV
Sponsor : Dong-A ST Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Naftopidil 75mg for Improving Clearance of Urinary Stones
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 13, 2013
Lead Product(s) : Naftopidil
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Sponsor : Dong-A ST Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Naftopidil
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Dong-A ST Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effect of Naftopidil for the Double-J Stent Discomfort
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 09, 2013
Lead Product(s) : Naftopidil
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Dong-A ST Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Naftopidil
Therapeutic Area : Urology
Study Phase : Phase III
Sponsor : Dong-A ST Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Medical Expulsive Therapy for Ureter Stone Using Naftopidil
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 27, 2013
Lead Product(s) : Naftopidil
Therapeutic Area : Urology
Highest Development Status : Phase III
Sponsor : Dong-A ST Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Naftopidil
Therapeutic Area : Urology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 14, 2013
Lead Product(s) : Naftopidil
Therapeutic Area : Urology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Naftopidil
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 16, 2010
Lead Product(s) : Naftopidil
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
